Case report
Interferon beta related pulmonary arterial hypertension; an emerging worrying entity?

https://doi.org/10.1016/j.msard.2015.03.008Get rights and content

Highlights

  • Pulmonary arterial hypertension as a rare side effect of interferon beta therapy.

  • Pulmonary arterial hypertension׳s clinical presentation described.

  • Pulmonary arterial hypertension reversal on cessation of interferon beta therapy.

Section snippets

Conflict of interest/role of funding

Dr Eavan Mc Govern has no financial disclosures to make.

Dr Eoin Judge has no financial disclosures to make.

Professor Sean Gaine has no financial disclosures to make.

Professor Tim Lynch has received grants from the Irish Institute of Clinical Neurosciences and the NIH (Grant No. RO1 NS078837-02). He has also received honaria from Biogen, Lundbeck, Orion and Teva and is on advisory boards from Biogen and Novartis

References (6)

There are more references available in the full text version of this article.

Cited by (0)

View full text